Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon Raises Additional $15M in Financing

NEW YORK (GenomeWeb) – Metabolon said today that it has raised an additional $15 million in funding from healthcare equity firm Essex Woodlands.

Essex Woodlands invested an initial $15 million in Metabolon in August.  At the time, the company said it planned to use  the money to develop and commercialize its pipeline of metabolomics technology-based precision medicine products. Metabolon also noted that Essex had the option to increase its investment by an additional $10 million, which would be used to repurchase shares from existing investors. 

Indeed, Metabolon said that the funds from Essex’s follow-on investment have already been used to repurchase and retire certain shares held by existing investors.

Including this latest investment, Metabolon has raised approximately $95 million in funding since it was founded in 2000.